{"success":true,"data":{"pressRelease":{"id":"158490","rtpr_id":"nBw9vhYVMa-20261001","ticker":"AMSU","exchange":"LSE","all_tickers":["AMSU"],"title":"REG-Millennium Partners, L.P. Form 8.3","author":"Business Wire","published_at":"2026-10-01T14:25:00.442Z","article_body":"Form 8.3\n\n \n\nFORM 8.3\n\nPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY\n\nA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE\n\nRule 8.3 of the Takeover Code (the “Code”)\n\n1. KEY INFORMATION\n (a) Full name of discloser:   Millennium International Management LP \n (b) Owner or controller of interests and short positions disclosed, if     \n different from 1(a): \n \n \n \nThe naming of nominee or vehicle companies is insufficient. For a trust, the \n trustee(s), settlor and beneficiaries must be named. \n (c) Name of offeror/offeree in relation to whose relevant securities this form   Advanced Medical Solutions Group plc \n relates: \n \n \n \nUse a separate form for each offeror/offeree \n (d) If an exempt fund manager connected with an offeror/offeree, state this     \n and specify identity of offeror/offeree: \n (e) Date position held/dealing undertaken:   30th September 2026 \n \n \n \nFor an opening position disclosure, state the latest practicable date prior to \n the disclosure \n (f) In addition to the company in 1(c) above, is the discloser making   No \n disclosures in respect of any other party to the offer? \n \n \n \nIf it is a cash offer or possible cash offer, state “N/A” \n\n\n2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE\n\nIf there are positions or rights to subscribe to disclose in more than one\nclass of relevant securities of the offeror or offeree named in 1(c), copy\ntable 2(a) or (b) (as appropriate) for each additional class of relevant\nsecurity.\n\n(a) Interests and short positions in the relevant securities of the offeror or\nofferee to which the disclosure relates following the dealing (if any)\n Class of relevant security:   5p ordinary (GB0004536594) \n     Interests   Short positions \n \n \n \n  \n   Number   %   Number   % \n (1) Relevant securities owned and/or controlled:   -   -   -   - \n (2) Cash-settled derivatives:   6,613,152   2.994%   -   - \n (3) Stock-settled derivatives (including options) and agreements to   -   -   -   - \n purchase/sell: \n TOTAL:   6,613,152   2.994%   -   - \n\n\nAll interests and all short positions should be disclosed.\n\nDetails of any open stock-settled derivative positions (including traded\noptions), or agreements to purchase or sell relevant securities, should be\ngiven on a Supplemental Form 8 (Open Positions).\n\n(b) Rights to subscribe for new securities (including directors’ and other\nemployee options)\n Class of relevant security in relation to which subscription right exists:     \n Details, including nature of the rights concerned and relevant percentages:     \n\n\n3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE\n\nWhere there have been dealings in more than one class of relevant securities\nof the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as\nappropriate) for each additional class of relevant security dealt in.\n\nThe currency of all prices and other monetary amounts should be stated.\n\n(a) Purchases and sales\n Class of relevant security   Purchase/sale   Number of securities   Price per unit (EUR) \n               \n\n\n(b) Cash-settled derivative transactions\n Class of relevant security   Product description   Nature of dealing   Number of reference securities   Price per unit \n \n \n \n \n \ne.g. CFD \ne.g. opening/closing a long/short position, increasing/reducing a long/short \n  \n position \n GB0004536594   Equity Swap   Increasing a Long Position   38,077   2.82 GBP \n GB0004536594   Equity Swap   Increasing a Long Position   1   2.82 GBP \n\n\n(c) Stock-settled derivative transactions (including options)\n\n(i) Writing, selling, purchasing or varying\n Class of relevant security   Product description e.g. call option   Writing, purchasing, selling, varying etc.   Number of securities to which option relates   Exercise price per unit   Type   Expiry date   Option money paid/ received per unit \n \n \n \ne.g. American, European etc. \n                               \n\n\n(ii) Exercise\n Class of relevant security   Product description   Exercising/ exercised against   Number of securities   Exercise price per unit \n \n \n \ne.g. call option \n                   \n \n \n \n  \n\n\n(d) Other dealings (including subscribing for new securities)\n Class of relevant security   Nature of dealing   Details   Price per unit (if applicable) \n \n \n \ne.g. subscription, conversion \n               \n \n \n \n  \n\n\n4. OTHER INFORMATION\n\n(a) Indemnity and other dealing arrangements\n Details of any indemnity or option arrangement, or any agreement or \n understanding, formal or informal, relating to relevant securities which may \n be an inducement to deal or refrain from dealing entered into by the person \n making the disclosure and any party to the offer or any person acting in \n concert with a party to the offer: \n \n \n \nIrrevocable commitments and letters of intent should not be included. If there \n are no such agreements, arrangements or understandings, state “none” \n   \n \n \n \nNONE \n \n \n \n  \n\n\n(b) Agreements, arrangements or understandings relating to options or\nderivatives\n Details of any agreement, arrangement or understanding, formal or informal, \n between the person making the disclosure and any other person relating to: \n \n \n \n(i) the voting rights of any relevant securities under any option; or \n \n \n \n(ii) the voting rights or future acquisition or disposal of any relevant \n securities to which any derivative is referenced: \n \n \n \nIf there are no such agreements, arrangements or understandings, state \n “none” \n   \n \n \n \nNONE \n \n \n \n  \n\n\n(c) Attachments\n Is a Supplemental Form 8 (Open Positions) attached?   NO \n\n Date of disclosure:   1st October 2026 \n Contact name:   Stephen Glasper \n Telephone number:   +44 203 398 2166 \n\n\nPublic disclosures under Rule 8 of the Code must be made to a Regulatory\nInformation Service and must also be emailed to the Takeover Panel at\nmonitoring@disclosure.org.uk (mailto:monitoring@disclosure.org.uk) . The\nPanel’s Market Surveillance Unit is available for consultation in relation\nto the Code’s disclosure requirements on +44 (0)20 7638 0129.\n\nThe Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk&esheet=54614434&newsitemid=20261001391033&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=1&md5=8aca786c37c4de0c38ef661ce622e907)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20261001391033/en/\n(https://www.businesswire.com/news/home/20261001391033/en/)\n\nMillennium Partners, L.P.\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw9vhYVMa-20261001","title":"REG-Millennium Partners, L.P. Form 8.3","author":"Business Wire","ticker":"AMSU","created":"2026-10-01T14:25:00.442Z","tickers":["AMSU"],"exchange":"LSE","article_body":"Form 8.3\n\n \n\nFORM 8.3\n\nPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY\n\nA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE\n\nRule 8.3 of the Takeover Code (the “Code”)\n\n1. KEY INFORMATION\n (a) Full name of discloser:   Millennium International Management LP \n (b) Owner or controller of interests and short positions disclosed, if     \n different from 1(a): \n \n \n \nThe naming of nominee or vehicle companies is insufficient. For a trust, the \n trustee(s), settlor and beneficiaries must be named. \n (c) Name of offeror/offeree in relation to whose relevant securities this form   Advanced Medical Solutions Group plc \n relates: \n \n \n \nUse a separate form for each offeror/offeree \n (d) If an exempt fund manager connected with an offeror/offeree, state this     \n and specify identity of offeror/offeree: \n (e) Date position held/dealing undertaken:   30th September 2026 \n \n \n \nFor an opening position disclosure, state the latest practicable date prior to \n the disclosure \n (f) In addition to the company in 1(c) above, is the discloser making   No \n disclosures in respect of any other party to the offer? \n \n \n \nIf it is a cash offer or possible cash offer, state “N/A” \n\n\n2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE\n\nIf there are positions or rights to subscribe to disclose in more than one\nclass of relevant securities of the offeror or offeree named in 1(c), copy\ntable 2(a) or (b) (as appropriate) for each additional class of relevant\nsecurity.\n\n(a) Interests and short positions in the relevant securities of the offeror or\nofferee to which the disclosure relates following the dealing (if any)\n Class of relevant security:   5p ordinary (GB0004536594) \n     Interests   Short positions \n \n \n \n  \n   Number   %   Number   % \n (1) Relevant securities owned and/or controlled:   -   -   -   - \n (2) Cash-settled derivatives:   6,613,152   2.994%   -   - \n (3) Stock-settled derivatives (including options) and agreements to   -   -   -   - \n purchase/sell: \n TOTAL:   6,613,152   2.994%   -   - \n\n\nAll interests and all short positions should be disclosed.\n\nDetails of any open stock-settled derivative positions (including traded\noptions), or agreements to purchase or sell relevant securities, should be\ngiven on a Supplemental Form 8 (Open Positions).\n\n(b) Rights to subscribe for new securities (including directors’ and other\nemployee options)\n Class of relevant security in relation to which subscription right exists:     \n Details, including nature of the rights concerned and relevant percentages:     \n\n\n3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE\n\nWhere there have been dealings in more than one class of relevant securities\nof the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as\nappropriate) for each additional class of relevant security dealt in.\n\nThe currency of all prices and other monetary amounts should be stated.\n\n(a) Purchases and sales\n Class of relevant security   Purchase/sale   Number of securities   Price per unit (EUR) \n               \n\n\n(b) Cash-settled derivative transactions\n Class of relevant security   Product description   Nature of dealing   Number of reference securities   Price per unit \n \n \n \n \n \ne.g. CFD \ne.g. opening/closing a long/short position, increasing/reducing a long/short \n  \n position \n GB0004536594   Equity Swap   Increasing a Long Position   38,077   2.82 GBP \n GB0004536594   Equity Swap   Increasing a Long Position   1   2.82 GBP \n\n\n(c) Stock-settled derivative transactions (including options)\n\n(i) Writing, selling, purchasing or varying\n Class of relevant security   Product description e.g. call option   Writing, purchasing, selling, varying etc.   Number of securities to which option relates   Exercise price per unit   Type   Expiry date   Option money paid/ received per unit \n \n \n \ne.g. American, European etc. \n                               \n\n\n(ii) Exercise\n Class of relevant security   Product description   Exercising/ exercised against   Number of securities   Exercise price per unit \n \n \n \ne.g. call option \n                   \n \n \n \n  \n\n\n(d) Other dealings (including subscribing for new securities)\n Class of relevant security   Nature of dealing   Details   Price per unit (if applicable) \n \n \n \ne.g. subscription, conversion \n               \n \n \n \n  \n\n\n4. OTHER INFORMATION\n\n(a) Indemnity and other dealing arrangements\n Details of any indemnity or option arrangement, or any agreement or \n understanding, formal or informal, relating to relevant securities which may \n be an inducement to deal or refrain from dealing entered into by the person \n making the disclosure and any party to the offer or any person acting in \n concert with a party to the offer: \n \n \n \nIrrevocable commitments and letters of intent should not be included. If there \n are no such agreements, arrangements or understandings, state “none” \n   \n \n \n \nNONE \n \n \n \n  \n\n\n(b) Agreements, arrangements or understandings relating to options or\nderivatives\n Details of any agreement, arrangement or understanding, formal or informal, \n between the person making the disclosure and any other person relating to: \n \n \n \n(i) the voting rights of any relevant securities under any option; or \n \n \n \n(ii) the voting rights or future acquisition or disposal of any relevant \n securities to which any derivative is referenced: \n \n \n \nIf there are no such agreements, arrangements or understandings, state \n “none” \n   \n \n \n \nNONE \n \n \n \n  \n\n\n(c) Attachments\n Is a Supplemental Form 8 (Open Positions) attached?   NO \n\n Date of disclosure:   1st October 2026 \n Contact name:   Stephen Glasper \n Telephone number:   +44 203 398 2166 \n\n\nPublic disclosures under Rule 8 of the Code must be made to a Regulatory\nInformation Service and must also be emailed to the Takeover Panel at\nmonitoring@disclosure.org.uk (mailto:monitoring@disclosure.org.uk) . The\nPanel’s Market Surveillance Unit is available for consultation in relation\nto the Code’s disclosure requirements on +44 (0)20 7638 0129.\n\nThe Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk&esheet=54614434&newsitemid=20261001391033&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=1&md5=8aca786c37c4de0c38ef661ce622e907)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20261001391033/en/\n(https://www.businesswire.com/news/home/20261001391033/en/)\n\nMillennium Partners, L.P.\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-10-01T14:25:00.505440204Z","server_sent_at_ms":1790864700505},"received_at":"2026-10-01T14:25:00.662Z","source_url":"https://www.businesswire.com/news/home/20261001391033/en/"},"analysis":{"id":"147108","press_release_id":"158490","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":[],"eventType":"regulatory","narrative":"Millennium International Management LP filed a UK Takeover Code Rule 8.3 disclosure on Advanced Medical Solutions Group plc, dated 30 September 2026.\n\nThe firm holds 6,613,152 cash-settled derivative references equal to 2.994% of the relevant securities, and increased its long position via equity swaps on 38,077 references at 2.82 GBP.\n\nNo irrevocable commitments, indemnity arrangements, or voting agreements were disclosed; this is routine takeover-era position disclosure.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine Rule 8.3 hedge-fund position disclosure during takeover window -- minimal signal."},"keyFigures":{"customDimensions":{"dealings":"equity swap increase of 38,077 references at 2.82 GBP, plus 1 reference at 2.82 GBP","disclosed_position":"6,613,152 cash-settled derivative references (2.994%)"}},"namedEntities":{"people":[{"name":"Stephen Glasper","role":"disclosure contact"}],"products":["Equity Swap"],"companies":[{"name":"Millennium International Management LP","relationship":"discloser/fund manager"},{"name":"Advanced Medical Solutions Group plc","ticker":"AMSU","relationship":"offeree/offeree in whose securities the disclosure relates"}],"dollarAmounts":[{"amount":"2.82 GBP","context":"price per unit of equity swap dealings"}]},"materialImpact":{"score":1,"reasoning":"Routine UK Takeover Code Rule 8.3 position disclosure by Millennium regarding Advanced Medical Solutions. Boilerplate regulatory filing with no new deal information or material change."},"tickerRelevance":{"others":[],"primary":"AMSU"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"routine-takeover-code-disclosure","issuerAuthored":false}},"event_type":"regulatory","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Millennium International Management LP filed a UK Takeover Code Rule 8.3 disclosure on Advanced Medical Solutions Group plc, dated 30 September 2026.\n\nThe firm holds 6,613,152 cash-settled derivative references equal to 2.994% of the relevant securities, and increased its long position via equity swaps on 38,077 references at 2.82 GBP.\n\nNo irrevocable commitments, indemnity arrangements, or voting agreements were disclosed; this is routine takeover-era position disclosure.","key_figures":{"customDimensions":{"dealings":"equity swap increase of 38,077 references at 2.82 GBP, plus 1 reference at 2.82 GBP","disclosed_position":"6,613,152 cash-settled derivative references (2.994%)"}},"named_entities":{"people":[{"name":"Stephen Glasper","role":"disclosure contact"}],"products":["Equity Swap"],"companies":[{"name":"Millennium International Management LP","relationship":"discloser/fund manager"},{"name":"Advanced Medical Solutions Group plc","ticker":"AMSU","relationship":"offeree/offeree in whose securities the disclosure relates"}],"dollarAmounts":[{"amount":"2.82 GBP","context":"price per unit of equity swap dealings"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-01T14:25:05.983Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"routine-takeover-code-disclosure","issuerAuthored":false}},"durationMs":5245,"modelName":"glm-5.3-flashx"}}